Recruiting

Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors

The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of…

ClinicalTrials.gov IDNCT06729684
PhaseNA
Enrollment72
SponsorSamsung Medical Center
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Breast Cancer Survivorship, Breast Cancer, Digital Health

About this study

The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Individuals who have undergone surgery for Stage 1-2 breast cancer * Individuals who have had a unilateral mastectomy * Aged 18 years or older and under 65 years * Possessing a smartphone with either an Android or iOS operating system * Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent Exclusion Criteria: * Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy * Individuals with severe comorbidities (such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc.) that make it difficult to use the application or participate in the exercise intervention Discontinuation Criteria * Individuals who undergo delayed breast reconstruction surgery during the study period * Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period, leading to a change in treatment * Occurrence of a major illness unrelated to study participation * Failure to comply with the instructions of the study physician * Situations where the participant voluntarily withdraws from the study or becomes unable to continue participating

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.